TY - JOUR
T1 - Salivary monoacetylated polyamines as noninvasive biomarkers for early detection and stratification of oral squamous cell carcinoma
T2 - A targeted metabolomics study
AU - Panneerselvam, Karthika
AU - Krishnan, Rajkumar
AU - Mahadevan, Sathishkumar
AU - Ayyadurai, Mathan Mohan
AU - Sugimoto, Masahiro
N1 - Publisher Copyright:
© 2026 Elsevier Ltd
PY - 2026/4
Y1 - 2026/4
N2 - Objectives: This study aimed to evaluate salivary monoacetylated polyamines as noninvasive biomarkers for the detection and staging of oral squamous cell carcinoma (OSCC). Design: Unstimulated saliva samples were collected from healthy controls (n = 15), oral leukoplakia (OLK) patients (n = 15), and OSCC patients stratified into early (n = 28) and advanced stages (n = 46). Seven polyamines were quantified using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Diagnostic performance was assessed via receiver operating characteristic (ROC) analysis, logistic regression modeling, and multivariate clustering. Results: N1-acetylspermidine and N1-acetylspermine showed progressive elevation from OLK to advanced OSCC, with AUCs of 0.87 and 0.81, respectively. A two-marker logistic model achieved a cross-validated AUC of 0.85, demonstrating good discriminatory performance between malignant and non-malignant states. Multivariate analysis confirmed their contribution to disease stratification, while calibration plots supported model reliability. Conclusions: Salivary N1-acetylspermidine and N1-acetylspermine are promising biomarkers for noninvasive OSCC detection and staging.
AB - Objectives: This study aimed to evaluate salivary monoacetylated polyamines as noninvasive biomarkers for the detection and staging of oral squamous cell carcinoma (OSCC). Design: Unstimulated saliva samples were collected from healthy controls (n = 15), oral leukoplakia (OLK) patients (n = 15), and OSCC patients stratified into early (n = 28) and advanced stages (n = 46). Seven polyamines were quantified using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Diagnostic performance was assessed via receiver operating characteristic (ROC) analysis, logistic regression modeling, and multivariate clustering. Results: N1-acetylspermidine and N1-acetylspermine showed progressive elevation from OLK to advanced OSCC, with AUCs of 0.87 and 0.81, respectively. A two-marker logistic model achieved a cross-validated AUC of 0.85, demonstrating good discriminatory performance between malignant and non-malignant states. Multivariate analysis confirmed their contribution to disease stratification, while calibration plots supported model reliability. Conclusions: Salivary N1-acetylspermidine and N1-acetylspermine are promising biomarkers for noninvasive OSCC detection and staging.
KW - Early detection
KW - LC-MS/MS
KW - Metabolomics
KW - Oral squamous cell carcinoma
KW - Polyamines
KW - Salivary biomarkers
UR - https://www.scopus.com/pages/publications/105028880203
UR - https://www.scopus.com/pages/publications/105028880203#tab=citedBy
U2 - 10.1016/j.archoralbio.2026.106513
DO - 10.1016/j.archoralbio.2026.106513
M3 - Article
C2 - 41633305
AN - SCOPUS:105028880203
SN - 0003-9969
VL - 184
JO - Archives of Oral Biology
JF - Archives of Oral Biology
M1 - 106513
ER -